Introduction
============

Refractory chronic immune thrombocytopenic purpura (ITP) is an auto-immune disorder with persistently low platelet count which is unresponsive to any recognised modality of treatment without unacceptable toxicity[@B1]. Surgical procedures carried out in patients with ITP involve risk of severe intra operative and postoperative bleeding and infection. Appropriate preoperative preparation of patients with severe ITP undergoing major joint replacement surgery is essential to avoid such complications.

We present a case report of a 61-year-old male patient with severe chronic refractory ITP who underwent cemented total knee replacement with careful and meticulous perioperative management.

Case Report
===========

A 61-year-old man with a history of ITP presented with chronic severe right knee pain. He had been suffering from ITP for eleven years and despite corticosteroids, dapsone and azathioprine treatment as well as previous splenectomy his platelet count remained in the range 20-30×10^9^/L with occasional dips to \<10×10^9^.

Clinical examination of the knee revealed a correctable varus deformity of five degrees with no fixed flexion deformity and knee flexion of ninety degrees. The skin quality around the knee was satisfactory with no distal neuro-vascular deficit. Radiographs of the knee ([Figs. 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}) confirmed severe osteoarthritis with absent joint space in the medial compartment of the right knee. Considering the severe changes on the X-rays and effect on his quality of life a decision to undertake a right sided cemented knee replacement was made. The possible risks involved were discussed at length with the patient by both the orthopaedic and haematology teams. After careful consideration he consented to proceed with the operation.

The patient received 28 g of intravenous immunoglobulin (IV Ig) per day (equivalent to 400 mg/kg for a 70 kg person) for five days prior to the knee replacement. A platelet count of 280×10^9^/L was achieved and it was deemed safe to carry out the procedure. As the patient had been receiving prednisolone at a dose of 10 mg daily for some months prior to the operation, hydrocortisone 150 mg was administered on the day of operation, according to the advice by the anaesthetic team. The operation was conducted under general anaesthesia with sciatic and femoral nerve blocks. Cemented total knee replacement was performed using midline skin incision with medial parapatellar approach. Cruciate retaining PFC sigma (DePuy Orthopaedics Inc, Warsaw, IN, USA) implant was used with Palacos cement (Heraeus, Wehrheim, Germany). Meticulous tissue handling was observed throughout the whole procedure. No alterations were made to the routinely used surgical technique and no drains were used at the end of the procedure. No additional blood conservation measures such as haemovac or cell saver were used. No particular difficulties were faced during the operation. A total tourniquet time of 75 minutes was noted.

Postoperatively, the patient was particularly observed for excessive bleeding from the operative wound and his platelet count was monitored daily. Low molecular weight heparin which is routinely recommended for prevention of venous thromboemobolism in patients undergoing major joint replacement surgery, was not prescribed due to high likelihood of postoperative bleeding in this case. Also, non steroidal anti-inflammatory drugs which are known to cause platelet dysfunction were avoided. Instead, mechanical thromboprophylaxis was used with anti-embolism stocking sand intermittent calf compression pumps.

On postoperative day one platelet count was 140×10^9^, on the second day platelet count dropped down to 137×10^9^ and on the third postoperative day it was 73×10^9^. In view of this, 28 g (400 mg/kg) of IV Ig per day was commenced on the third postoperative day for another three days after discussion with the haematology team. At this stage, low molecular weight heparin was commenced to counter the hypercoagulability state known to be caused by intravenous immunoglobulins[@B2]. His platelet count dropped down to 37×10^9^ on postoperative day four. On day seven the platelet count improved to 190×10^9^.

Routine postoperative ambulation was carried out. The patient was mobilised with the aid of crutches initially. He was discharged from the hospital on the eighth postoperative day after achieving independent walking with stair climbing and knee flexion of 80 degrees.

The patient was reviewed in the haematology clinic three days following discharge from the hospital. The platelet count measured then was 327×10^9^. His platelet count trend is shown in [Fig. 3](#F3){ref-type="fig"}. He was reviewed in the orthopaedic clinic after one week, three week and six weeks. The postoperative radiographs of his knee were satisfactory ([Figs. 4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}). No complications were observed. At three months follow-up 130° of knee flexion was achieved. His postoperative Oxford Knee score was calculated to be 40. The patient was able to carry out all the activities of daily living including driving and he was very satisfied with the outcome.

Discussion
==========

This report describes a case of severe refractory chronic ITP undergoing cemented total knee replacement surgery for severe osteoarthritis of the knee. Successful result was achieved with constant supervision, careful monitoring and multi-disciplinary team approach.

ITP is an immune disorder characterised by auto antibodies formation against platelets leading to accelerated platelet destruction and retarded platelet production[@B1]. The prevalence of ITP in adults in the UK is approximately 5.8 to 6.6 per 100,000. As compared to ITP in children, ITP in adults often runs a chronic course and in about 10% of adult patients are refractory to treatment[@B3]. The risk of bleeding requiring treatment increase with increasing severity of thrombocytopenia and is highest in patients with platelet count of \<20×10^9^/L[@B4]. Treatment is seldom required with the platelet count of more than 30×10^9^/L unless the patient is undergoing a surgical procedure. Platelet count of more than 80×10^9^/L is the recommended level for undertaking major surgery[@B5]. Treatment options are categorized into first line and second line therapy. First line includes oral steroid therapy and pooled human immunoglobulins. Second line therapy includes splenectomy, intravenous anti-D, androgen therapy (Danazol) and immunosuppressive drugs such as vinca alkaloids, azathioprine, cyclosporine A and rituximab. High dose intravenous immunoglobulins along with coticosteroids have been shown to stimulate early response which might be particularly useful in surgical patients[@B5].

Many cases with ITP undergoing cardio vascular surgery[@B6] and cancer surgery[@B7] have been reported but limited case reports of such patients undergoing major orthopaedic operations have been described. Kim et al.[@B8] described a series of five patients undergoing total hip replacement for osteonecrosis of femoral head related to underlying ITP. Most of the patients described in this article were less than 60 year of age at the time of surgery. Nezu et al.[@B9] illustrated a 42-year-old with refractory ITP receiving hip replacement under the cover of vinca alkaloids and colchicine as the platelet count could not be elevated by the first line and second line therapy. However, to our knowledge, no case of total knee replacement in patient with ITP has been described in the literature and there are no specific guidelines issued regarding the perioperative management of such patients.

Patients older than 60 years and those with previous history of bleeding are at higher risk of complications[@B4]. Post operative intra-articular warrants special consideration in cases of knee replacement as compared to hip replacement because of the risk of arthrofibrosis due to bleeding leading to knee stiffness. Bone cuts made during knee replacement surgery results in large raw surfaces of bone with high potential of bleeding. In the present case, cement was used to cover the bleeding bony surfaces as cemented knee replacement has been shown to result in lower perioperative blood loss as compared to uncemented knee replacement[@B10].

The clinical needs and perioperative management of patients undergoing an emergency operation are different from that of those undergoing elective surgery such as a joint replacement procedure, which can be deferred for indefinite period as the procedure is not life saving. Surgeons might postpone knee or hip replacement, which is mainly undertaken to improve the quality of life, if the expected intra or post operative complications are deemed to be life threatening. With specific guidelines, scrupulous preparation, close communication and constant monitoring these procedures can be conducted with a successful outcome.

ITP is a complex disorder. Close monitoring is paramount to prevent severe complications. Medical therapy and appropriate surgical technique can minimise complications in patients with severe refractory ITP undergoing total knee replacement.
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